Avinger Inc. (AVGR): שווי שוק להכנסות

Avinger, Inc. management is betting on the development of innovative laser systems for vascular therapy. Consistent sales of surgical consumables create a steady cash flow and support margins. However, the aggressive promotion of these systems is leading to a temporary liquidity shortage. The estimated price-to-sales ratio reflects the market valuation of the business, with this metric equal to 0.20.

For Avinger, Inc., whose model is based on recurring sales of vascular surgery consumables, the current P/S valuation of 0.20 reflects market confidence in revenue stability. This multiple compares market capitalization to sales volume, allowing investors to identify any imbalance in the asset's value relative to its ability to generate cash flow.